SUNG-RAN CHO: Open Payments
NPI 1497796379 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 84 payments from 10 companies in 2025. Trend: 2023 $1,156 · 2024 $961 · 2025 $1,682
Food & beverage: $1,570Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $391 |
| Teva Pharmaceuticals USA, Inc. | 12 | $262 |
| Alkermes, Inc. | 11 | $218 |
| ABBVIE INC. | 9 | $208 |
| Indivior Inc. | 8 | $198 |
| Neurocrine BioSciences, Inc. | 13 | $193 |
| Janssen Pharmaceuticals, Inc | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, SUBLOCADE, INGREZZA, ARISTADA, UZEDY, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
